Pimavanserin
Showing 26 - 40 of 40
Adjunctive Treatment of MDD Trial in Worldwide (Pimavanserin, Placebo)
Completed
- Adjunctive Treatment of Major Depressive Disorder
- Pimavanserin
- Placebo
-
Helsinki, Finland
- +43 more
Jun 25, 2020
Adjunctive Treatment of MDD Trial in United States (Pimavanserin, Placebo)
Completed
- Adjunctive Treatment of Major Depressive Disorder
- Pimavanserin
- Placebo
-
Birmingham, Alabama
- +35 more
Oct 25, 2019
Agitation and Aggression in Alzheimer's Disease Trial in Worldwide (Pimavanserin 34 mg, Pimavanserin 20 mg, Placebo)
Terminated
- Agitation and Aggression in Alzheimer's Disease
- Pimavanserin 34 mg
- +2 more
-
Costa Mesa, California
- +55 more
Mar 7, 2019
Dementia Trial in Exeter (COVID WHELD)
Recruiting
- Dementia
- COVID WHELD
-
Exeter, Devon, UK, United KingdomUniversity of Exeter
May 25, 2021
Parkinson's Disease Psychosis Trial in Worldwide (Pimavanserin tartrate (ACP-103))
Completed
- Parkinson's Disease Psychosis
- Pimavanserin tartrate (ACP-103)
-
Gilbert, Arizona
- +134 more
May 29, 2019
Parkinson Disease Psychosis Trial in London (Saracatinib, Placebo Oral Tablet)
Unknown status
- Parkinson Disease Psychosis
- Saracatinib
- Placebo Oral Tablet
-
London, Camberwell, United KingdomMitul Mehta
Aug 12, 2019
Alzheimer's Disease Psychosis Trial in London (Pimavanserin tartrate, Placebo)
Completed
- Alzheimer's Disease Psychosis
- Pimavanserin tartrate
- Placebo
-
London, United Kingdom(unnamed)
Sep 28, 2017
Parkinson's Disease Psychosis Trial (Pimavanserin tartrate)
Approved for marketing
- Parkinson's Disease Psychosis
- Pimavanserin tartrate
- (no location specified)
Apr 17, 2017
Parkinson's Disease Psychosis Trial in Worldwide (Pimavanserin tartrate (ACP-103))
Completed
- Parkinson's Disease Psychosis
- Pimavanserin tartrate (ACP-103)
-
La Habra, California
- +49 more
Apr 18, 2017
Parkinson's Disease Psychosis Trial in Worldwide (Pimavanserin tartrate (ACP-103), Placebo)
Completed
- Parkinson's Disease Psychosis
- Pimavanserin tartrate (ACP-103)
- Placebo
-
Gilbert, Arizona
- +77 more
Apr 18, 2017
Parkinson's Disease, Dyskinesias Trial run by the NINDS (Intravenous Levodopa, ACP-103)
Completed
- Parkinson's Disease
- Dyskinesias
- Intravenous Levodopa
- ACP-103
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017
Parkinson's Disease Psychosis Trial in Canada, United States (pimavanserin tartrate, )
Completed
- Parkinson's Disease Psychosis
- pimavanserin tartrate
- placebo
-
Gilbert, Arizona
- +62 more
Feb 6, 2014